January 16, 2023
On an average day, you might find Phoebe playing tennis, practicing cello, or enjoying time with family. Nothing can hold this active 11-year-old back — especially not myopia. Just over two years ago, Phoebe became one of the first children in the U.S. to be treated with MiSight 1 day contact lenses for myopia control± when it became available in 2020 following its 2019 FDA approval.*
Her story begins at age 8 when she began having trouble playing sports, seeing the whiteboard at school, and focusing throughout her daily life. While glasses cleared up her blurry vision, her myopia continued to worsen, and additional concerns began to arise. Phoebe worried that she would be hit in the face while playing sports or forget her glasses and not be able to see well.
Recalling this period, Phoebe’s mother shares, “I refused to let myopia limit my child.” She knew action was the only answer.
Fortunately, MiSight 1 day had recently become the first and only soft contact lens FDA approved to slow the progression of myopia in children aged 8 to 12 at initiation of treatment.*†1 Dr. Andrew Neukirch of Carillon Vision Care, with locations throughout Illinois, prescribed the lens for Phoebe, and her mother was immediately on board. She was excited to hear that the lenses were both FDA approved and daily disposable.
Phoebe started using MiSight, and immediately her life changed. She shares, “My contacts help me stay determined and stay focused because there are no distractions. I can focus on what I’m trying to do and what I’m trying to achieve. My vision’s perfect.”‡1,2
Her myopia progression has also slowed drastically.҂1 “Definitely start it early,” Phoebe recommends. “Because if you catch it late, you can’t go back.”
Her mother adds, “I’m just really excited that there’s an option out there for us as parents who really care about the vision of our kids, and I think that is something that all parents should be looking into if you have kids who have myopia.”
As you work to educate parents and children about myopia in your practice, stories such as Phoebe’s can be valuable resources to share with them. Visit the MiSight Digital Ecosystem across YouTube, Instagram, Facebook, and the MiSight website for more real-life myopia patient stories.
*U.S. Indications for use: MiSight 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
± Soft contact lens designed for myopia control in the U.S.
†Compared to a single vision 1 day lens over a three-year period.
‡ VA (LogMAR) > 6/6 (20/20) at all visits from dispensing to six-year visit.
҂ Compared to single vision lens. -0.25D or less of change. Fitted at 8-12 years of age at initiation of treatment.
1 Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci. 2019; 96(8)556-567.
2 Chamberlain P, Arumugam B, Jones D et al. Myopia Progression in Children wearing Dual-Focus Contact Lenses: 6-year findings. Optom Vis Sci 2020;97(E-abstract):200038.